RXRX (STOCKS)
Recursion Pharmaceuticals, Inc. Class A Common Stock
$3.290000
+0.140000 (+4.44%)
Prev close: $3.150000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Najat Khan
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $1,746.21M
- Employees
- 800
- P/E (TTM)
- -2.74
- P/B (TTM)
- 1.63
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $66.41M |
| Benefits Costs and Expenses | $630.77M |
| Cost Of Revenue | $61.61M |
| Costs And Expenses | $651.68M |
| Gross Profit | $4.80M |
| Nonoperating Income/Loss | $20.91M |
| Operating Expenses | $590.06M |
| Research and Development | $433.53M |
| Other Operating Expenses | $156.53M |
| Operating Income/Loss | -$585.27M |
| Income/Loss From Continuing Operations After Tax | -$559.78M |
| Income/Loss From Continuing Operations Before Tax | -$564.36M |
| Income Tax Expense/Benefit | -$4.58M |
| Income Tax Expense/Benefit, Deferred | -$4.55M |
| Net Income/Loss | -$559.78M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$559.78M |
| Net Income/Loss Available To Common Stockholders, Basic | -$559.78M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$1.16 |
| Diluted Earnings Per Share | -$1.16 |
| Basic Average Shares | 1,418,456,633 |
| Diluted Average Shares | 1,418,456,633 |
| Assets | $1.34B |
| Current Assets | $709.56M |
| Prepaid Expenses | $11.74M |
| Other Current Assets | $697.82M |
| Noncurrent Assets | $629.97M |
| Fixed Assets | $95.81M |
| Intangible Assets | $294.07M |
| Other Non-current Assets | $240.08M |
| Liabilities | $314.75M |
| Current Liabilities | $129.70M |
| Accounts Payable | $20.35M |
| Wages | $14.57M |
| Other Current Liabilities | $94.79M |
| Noncurrent Liabilities | $185.05M |
| Equity | $1.02B |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $1.02B |
| Liabilities And Equity | $1.34B |
| Net Cash Flow From Operating Activities | -$320.95M |
| Net Cash Flow From Operating Activities, Continuing | -$320.95M |
| Net Cash Flow From Investing Activities | -$9.94M |
| Net Cash Flow From Investing Activities, Continuing | -$9.94M |
| Net Cash Flow From Financing Activities | $477.54M |
| Net Cash Flow From Financing Activities, Continuing | $477.54M |
| Exchange Gains/Losses | $9.38M |
| Net Cash Flow | $156.02M |
| Net Cash Flow, Continuing | $146.64M |
| Comprehensive Income/Loss | -$547.26M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$547.26M |
| Other Comprehensive Income/Loss | -$547.26M |
| Other Comprehensive Income/Loss Attributable To Parent | $12.52M |